E Charlier, C Deroyer, F Ciregia, O Malaise… - Biochemical …, 2019 - Elsevier
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage degradation but also synovial membrane inflammation, osteophyte formation and …
Osteoarthritis (OA), one of the most common rheumatic disorders, is characterized by cartilage breakdown and by synovial inflammation that is directly linked to clinical symptoms …
A Latourte, C Cherifi, J Maillet, HK Ea… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the impact of systemic inhibition of interleukin 6 (IL-6) or signal transducer and activator of transcription (Stat3) in an experimental model of osteoarthritis …
H Bliddal, AR Leeds, R Christensen - Obesity reviews, 2014 - Wiley Online Library
Obesity is widely acknowledged as a risk factor for both the incidence and progression of osteoarthritis, and has a negative influence on outcomes. Loss of at least 10% of body …
O Stannus, G Jones, F Cicuttini… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: The role of inflammation in osteoarthritis (OA) pathogenesis is unclear, and the associations between inflammatory cytokines and cartilage loss have not been reported. We …
J Jann, S Gascon, S Roux, N Faucheux - International journal of …, 2020 - mdpi.com
The balance between bone forming cells (osteoblasts/osteocytes) and bone resorbing cells (osteoclasts) plays a crucial role in tissue homeostasis and bone repair. Several hormones …
OBJECTIVES: Dental tissue disease and trauma provides an excellent model for the interaction between tissue defence and regenerative processes and has application to many …
AG Robling, CH Turner - Critical Reviews™ in Eukaryotic Gene …, 2009 - dl.begellhouse.com
Proper development of the skeleton in utero and during growth requires mechanical stimulation. Loading results in adaptive changes in bone that strengthen bone structure …
P Richette, A Latourte, J Sellam, D Wendling… - Annals of the …, 2021 - ard.bmj.com
Objective To evaluate the efficacy of tocilizumab, an antibody against IL-6 receptor, in patients with hand osteoarthritis. Methods This was a multicentre, 12-week, randomised …